COMMUNIQUÉS West-GlobeNewswire

Karmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non-Hodgkin Lymphoma

27/03/2018 - 14:05

DETROIT, March 27, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute in Detroit is the first center in Michigan approved to treat adult patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) [...]

Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection

27/03/2018 - 14:00

NasoVAX intranasal influenza vaccine demonstrated strong cellular immune response and 100% seroprotection HepTcell vaccine was well tolerated but T-cell immunogenicity results were inconclusive GAITHERSBURG, Md., March [...]

Krystal Submits Investigational New Drug (IND) Application for KB103, Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa

27/03/2018 - 14:00

KB103 is an internally generated modified HSV-1 based gene therapy candidate engineered with a COL7A1 gene construct to treat Dystrophic Epidermolysis Bullosa (DEB) Therapeutic candidate formulated into a topical gel [...]

HTG Molecular Diagnostics Secures Debt Facility with MidCap Financial

27/03/2018 - 14:00

TUCSON, Ariz., March 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications today announced that it has [...]

Pernix Therapeutics Announces Return to Market of Zohydro® ER with BeadTek® 20 mg

27/03/2018 - 14:00

MORRISTOWN, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that it expects to resume distribution of the 20 mg dosage [...]

Athenex to Present at the 17th Annual Needham Healthcare Conference

27/03/2018 - 14:00

BUFFALO, N.Y., March 27, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

VANC Pharmaceuticals Appoints Dr. Robert Sindelar to Board of Directors

27/03/2018 - 14:00

VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic drug, over-the- [...]

Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles

27/03/2018 - 14:00

MADISON, Wis., March 27, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]

Tyme Announces First Site Open for its Phase II Trial with SM-88 in Pancreatic Cancer

27/03/2018 - 14:00

NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that the first site for the Phase II clinical trial evaluating SM-88 therapy for metastatic [...]

Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

27/03/2018 - 14:00

-- Initiated URIROX-1™, First Phase 3 Trial of ALLN-177 in Enteric Hyperoxaluria; Topline Data Expected in Second Half of 2019 – -- Initiated Phase 2 Trial of ALLN-177 for Patients with Primary Hyperoxaluria or Enteric [...]

Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis

27/03/2018 - 14:00

NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ: FBIO ) Company developing treatments for rare and life-threatening diseases, today announced a new [...]

Tower One Wireless Retains Former Ericsson Telecom Senior Executive

27/03/2018 - 14:00

VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has retained Mr. John Logiudice, a telecom [...]

Adherium Receives U.S. 510(k) Clearance for Over-the-Counter Sales of its Smartinhaler™ Sensor

27/03/2018 - 14:00

SAN MATEO, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the U.S. Food and Drug Administration (FDA) has [...]

RedHill Biopharma Announces Two Oral Presentations on BEKINDA® 24 mg for acute gastroenteritis at the SAEM 2018 Annual Meeting

27/03/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing

27/03/2018 - 14:00

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it has entered into a securities purchase agreement to sell $120.5 million of unsecured [...]

Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad

27/03/2018 - 13:30

MENLO PARK, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio ® [...]

NexImmune Announces Management and Board Appointments

27/03/2018 - 13:30

Scott Carmer appointed Chief Executive Officer Kristi Jones promoted to Chief Operating Officer Alan Roemer appointed Chairman of the Board of Directors GAITHERSBURG, Md., March 27, 2018 (GLOBE NEWSWIRE) -- NexImmune, [...]

Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution

27/03/2018 - 13:05

PETALUMA, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]

Immunovaccine Announces Webcast of R&D Update and Investor Event

27/03/2018 - 13:05

HALIFAX, Nova Scotia, March 27, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will webcast its ‘R&D Update and Investor [...]